Skip to main content
. Author manuscript; available in PMC: 2022 Aug 1.
Published in final edited form as: Int Forum Allergy Rhinol. 2020 Dec 4;11(8):1162–1176. doi: 10.1002/alr.22743

Table 7:

GO and Reactome pathways in normosmic versus dysosmic subjects

Cluster color from heat map Gene Ontology and Reactome pathway Size Intersection/Category size p-value FDR

Enriched in Dysosmic
Peach Overall Number of Proteins in Cluster 18 1.67E-16 2.51E-16
Cytoplasmic translation [GO:0002181] 7/23 4.97E-09 1.38E-05
Polysomal ribosome [GO:0042788] 5/18 1.94E-06 0.000639
Cytosolic large ribosomal subunit [GO:0022625] 10/37 2.99E-12 2.14E-09
Structural constituent of ribosome [GO:0003735] 14/65 3.02E-16 2.44E-12
SRP-dependent cotranslational protein targeting to membrane [GO:0006614] 14/67 4.81E-16 1.2E-11
Nuclear-transcribed mRNA catabolic process, nonsense-mediated decay [GO:0000184] 14/76 3.28E-15 4.11E-11
Translation [GO:0006412] 14/79 5.88E-15 4.91E-11
L13a-mediated translational silencing of Ceruloplasmin expression pathway 14/83 1.23E-14 2.55E-11
Translational initiation [GO:0006413] 14/90 4.13E-14 2.58E-10
Nucleolus [GO:0005730] 7/90 8.44E-05 0.019025
Focal adhesion [GO:0005925] 9/137 2.1E-05 0.005619
RNA binding [GO:0003723] 14/282 3.85E-07 0.001038
Membrane [GO:0016020] 15/323 1.89E-07 8.1E-05

Light Blue Overall Number of Proteins in Cluster 53 2.11E-49 6.32E-49
Positive regulation of cholesterol esterification [GO:0010873] 4/5 1.12E-05 0.018638
Membrane attack complex [GO:0005579] 5/7 1.68E-06 0.0006
Terminal pathway of complement pathway 5/7 1.68E-06 0.001157
Complement activation, alternative pathway [GO:0006957] 6/9 2.37E-07 0.00054
Negative regulation of endopeptidase activity [GO:0010951] 13/26 1.03E-12 5.18E-09
Serine-type endopeptidase inhibitor activity [GO:0004867] 14/30 4.07E-13 1.65E-09
Acute-phase response [GO:0006953] 6/14 7.06E-06 0.012625
Platelet alpha granule lumen [GO:0031093] 10/26 1.41E-08 8.6E-06
Blood microparticle [GO:0072562] 31/84 3.6E-26 1.54E-22
Cellular protein metabolic process [GO:0044267] 15/48 5.54E-11 2.31E-07
Regulation of complement activation [GO:0030449] 13/42 1.53E-09 5.47E-06
Collagen-containing extracellular matrix [GO:0062023] 23/76 1.56E-16 1.67E-13
Platelet degranulation [GO:0002576] 13/43 2.12E-09 6.65E-06
Platelet degranulation pathway 13/48 9.55E-09 9.86E-06
Endoplasmic reticulum lumen [GO:0005788] 12/48 1.04E-07 5.56E-05
Complement activation, classical pathway [GO:0006958] 11/49 1.23E-06 0.00257
Extracellular space [GO:0005615] 41/252 5.76E-21 8.22E-18
Extracellular region [GO:0005576] 45/307 3.04E-22 6.51E-19

Decreased in Dysosmic
Dark Pink Overall Number of Proteins in Cluster 20 2.67E-18 5.33E-18
Epidermis development [GO:0008544] 4/9 4.55E-06 0.00876

Black Overall Number of Proteins in Cluster 86 8.53E-84 5.12E-83
Oxidation-reduction process [GO:0055114] 11/23 3.16E-08 7.93E-05

Enrichment of GO terms associated with protein clusters was performed using a Fisher exact test with a Benjamini-Hochberg FDR<0.02. CRSwNP, chronic rhinosinusitis with nasal polyposis;

*

=unadjusted p-value; FDR=false discovery rate.